{"schema_version":"secwatch.filing_event.v1","accession":"0001828318-24-000229","form_type":"8-K","ticker":"ENVX","cik":"0001828318","company_name":"Enovix Corp","filed_at":"2024-10-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.874333+00:00","generated_at":"2026-05-30T09:22:53.050741+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Enovix Q3 revenue $4.3M, GAAP net loss $22.5M; opens Fab2, secures second smartphone OEM partnership","bullets":["Revenue $4.3M (above guidance midpoint), up from $3.8M Q2; GAAP net loss $22.5M improved from $115.9M Q2.","Opened Fab2 in Malaysia; commenced shipping EX-1M cells; completed UN38.3 safety certification.","Signed development agreement with second leading smartphone OEM for mass production launch in late 2025.","Q4 2024 guidance: revenue $8-10M, GAAP EPS loss $0.23-0.29, adjusted EBITDA loss $19-25M.","Cash $200.9M at quarter-end; on track to reduce cash consumption with Malaysia ops."],"urls":{"canonical":"https://secwatch.observer/filing/0001828318-24-000229","json":"https://secwatch.observer/filing/0001828318-24-000229.json","markdown":"https://secwatch.observer/filing/0001828318-24-000229.md","text":"https://secwatch.observer/filing/0001828318-24-000229.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1828318/000182831824000229/0001828318-24-000229-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1828318/000182831824000229/envx-20241029.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T09:22:53.050741+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}